Spherical macroporous poly(lactic-co-glycolic acid) (PLGA) has been synthesised using an emulsion method. Polyvinyl alcohol and Pluronic F127 have been used as dispersing and porogen agent, respectively. The diameter of the spherical PLGA is about 20 μm and the pore size of the PLGA macroporous is about 2–2.5 μm observed by scanning electron microscopy. After immersing in simulated body fluid, the PLGA materials can induce the formation of hydroxyapatite (HAP) on their surface. The HAP-PLGA has been obtained and used as the host for drug release. Furthermore, the drug-loaded samples possess the various drug release performance by adjusting the thickness of the HAP layer. This highly satisfied composite material is expected to be promising in the applications in tissue regeneration engineering.

References

1. 1)
  - 4. Kim, H.W., Knowles, J.C., Kim, H.E.: ‘Hydroxyapatite/poly(ɛ-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery’, Biomaterials, 2004, 25, pp. 1279–1287 (doi: 10.1016/j.biomaterials.2003.07.003).
2. 2)
  - 13. Murphy, W.L., Mooney, D.J.: ‘Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata’, J. Am. Chem. Soc., 2002, 124, pp. 1910–1917 (doi: 10.1021/ja012433n).
3. 3)
  - 8. Lu, H., Zhang, T., Wang, X.P., Fang, Q.F.: ‘Electrospun submicron bioactive glass fibers for bone tissue scaffold’, J. Mater. Sci. Mater. Med., 2009, 20, pp. 793–798 (doi: 10.1007/s10856-008-3649-1).
4. 4)
  - T. Kokubo , H. Kushitani , S. Sakka , T. Kitsugi , T. Yamamuro . Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J. Biomed. Mater. Res. , 721 - 734
5. 5)
  - 20. Saravanapavan, P., Jones, J.R., Pryce, R.S., Hench, L.L.: ‘Bioactivity of gel–glass powders in the CaO-SiO2 system: a comparison with ternary (CaO-P2P5-SiO2) and quaternary glasses (SiO2-CaO-P2O5-Na2O)’, J. Biomed. Mater. Res., 2003, 66A, pp. 110–119 (doi: 10.1002/jbm.a.10532).
6. 6)
  - 18. Zhu, M., Zhang, L.X., He, Q.J., Zhao, J.J., Guo, L.M., Shi, J.L.: ‘Mesoporous bioactive glass-coated poly(L-lactic acid) scaffolds: a sustained antibiotic drug release system for bone repairing’, J. Mater. Chem., 2011, 21, pp. 1064–1072 (doi: 10.1039/c0jm02179b).
7. 7)
  - 5. Alvarez, K., Nakajima, H.: ‘Metallic scaffolds for bone regeneration’, Materials, 2009, 2, pp. 790–832 (doi: 10.3390/ma2030790).
8. 8)
  - M. Wang . Developing bioactive composite materials for tissue replacement. Biomaterials , 2133 - 2151
9. 9)
  - 6. Prabaharan, M., Rodriguez-Perez, M.A., de Saja, J.A., Mano, J.F.: ‘Preparation and characterization of poly(L-lactic acid)-chitosan hybrid scaffolds with drug release capability’, J. Biomed. Mater. Res. B, Appl. Biomater., 2007, 81B, pp. 427–434 (doi: 10.1002/jbm.b.30680).
10. 10)
  - 21. Olmo, N., Martin, A.I., Salinas, A.J., Turnay, J., Vallet-Regi, M., Lizarbe, M.A.: ‘Bioactive sol–gel glasses with and without a hydroxycarbonate apatite layer as substrates for osteoblast cell adhesion and proliferation’, Biomaterials, 2003, 24, pp. 3383–3393 (doi: 10.1016/S0142-9612(03)00200-X).
11. 11)
  - 17. Farokhi, M., Shariﬁ, S., Shaﬁeyan, Y., et al: ‘Porous crosslinked poly(ɛ-caprolactone fumarate)/nanohydroxyapatite composites for bone tissue engineering’, J. Biomed. Mater. Res. A, 2012, 100A, pp. 1051–1060 (doi: 10.1002/jbm.a.33241).
12. 12)
  - 10. Cooke, F.W.: ‘Ceramics in orthopedic surgery’, Cli. Orthop., 1992, 276, p. 135146.
13. 13)
  - 7. Rahaman, M.N., Day, D.E., Bal, B.S., et al: ‘Bioactive glass in tissue engineering’, Acta Biomaterialia, 2011, 7, pp. 2355–2373 (doi: 10.1016/j.actbio.2011.03.016).
14. 14)
  - 12. Terai, H., Hannouche, D., Ochoa, E., Yamano, Y., Vacanti, J.P.: ‘In vitro engineering of bone using a rotational oxygen-permeable bioreactor system’, Mater. Sci. Eng. C, 2002, 20, pp. 3–8 (doi: 10.1016/S0928-4931(02)00006-1).
15. 15)
  - 14. Watanabe, J., Akashi, M.: ‘Formation of hydroxyapatite provides a tunable protein reservoir within porous polyester membranes by an improved soaking process’, Biomacromolecules, 2007, 8, pp. 2288–2293 (doi: 10.1021/bm0702915).
16. 16)
  - 1. Kim, H., Kim, H.W., Suh, H.: ‘Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells’, Biomaterials, 2003, 24, pp. 4671–4679 (doi: 10.1016/S0142-9612(03)00358-2).
17. 17)
  - 6. Allo, B.-A., Rizkalla, A.-S., Mequanint, K.: ‘Synthesis and electrospinning of ɛ-polycaprolactone-bioactive glass hybrid biomaterials via a sol–gel process’, Langmuir, 2010, 26, (23), pp. 18340–18348 (doi: 10.1021/la102845k).
18. 18)
  - 3. Rose, F., Oreffo, R.: ‘Bone tissue engineering: hope vs Hype’, Biochem. Biophys. Res. Commun., 2002, 292, pp. 1–7 (doi: 10.1006/bbrc.2002.6519).
19. 19)
  - 2. Petite, H., Viateau, V., Bensaid, W., et al: ‘Tissue-engineered bone regeneration’, Nature Biotechnol., 2000, 18, pp. 959–963 (doi: 10.1038/79449).
20. 20)
  - L.L. Hench , J.M. Polak . Third-generation biomedical materials. Science , 1014 - 1017
21. 21)
  - M. Vallet-Regi . Ceramics for medical applications. J. Chem. Soc. Dalton Trans. , 97 - 108

Preparation of spherical macroporous poly(lactic-co-glycolic acid) for bone tissue regeneration

References

Related content